These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35633535)
1. Antiproliferative Activities of Lipophililic Fluoroquinolones- Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines. Qashou E; Al-Hiari Y; Kasabri V; AlBashiti R; AlAlawi S; Telfah A; AlHadid A Asian Pac J Cancer Prev; 2022 May; 23(5):1529-1537. PubMed ID: 35633535 [TBL] [Abstract][Full Text] [Related]
3. Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines. Salih MAF; Al-Hiari Y; Kasabri V; Darwish R; Abumansour H; Bourghli L; Al Alawi S; Albashiti R Asian Pac J Cancer Prev; 2022 Jul; 23(7):2507-2521. PubMed ID: 35901360 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines. Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411 [TBL] [Abstract][Full Text] [Related]
5. Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds. Haj Hussein B; Kasabri V; Al-Hiari Y; Arabiyat S; Ikhmais B; Alalawi S; Al-Qirim T Asian Pac J Cancer Prev; 2022 Dec; 23(12):4047-4062. PubMed ID: 36579985 [TBL] [Abstract][Full Text] [Related]
6. Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds. AlKhalil M; Al-Hiari Y; Kasabri V; Arabiyat S; Al-Zweiri M; Mamdooh N; Telfah A Drug Dev Res; 2020 Jun; 81(4):470-490. PubMed ID: 31943302 [TBL] [Abstract][Full Text] [Related]
7. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones. Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926 [TBL] [Abstract][Full Text] [Related]
8. Antilipase and antiproliferative activities of novel fluoroquinolones and triazolofluoroquinolones. Arabiyat S; Kasabri V; Al-Hiari Y; Bustanji YK; Albashiti R; Almasri IM; Sabbah DA Chem Biol Drug Des; 2017 Dec; 90(6):1282-1294. PubMed ID: 28639358 [TBL] [Abstract][Full Text] [Related]
9. A Novel Class of Functionalized Synthetic Fluoroquinolones with Dual Antiproliferative - Antimicrobial Capacities. Al-Nuaimi A; Al-Hiari Y; Kasabri V; Haddadin R; Mamdooh N; Alalawi S; Khaleel S Asian Pac J Cancer Prev; 2021 Apr; 22(4):1075-1086. PubMed ID: 33906299 [TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Rutin-Encapsulated Polymeric Micelles and Studies of Synergism with Bioactive Benzoic Acids and Triazolofluoroquinolones as Anticancer Nanomedicines. Ibrahim R; Kasabri V; Sunoqrot S; Shalabi D; Alkhateeb R; Alhiari Y Asian Pac J Cancer Prev; 2023 Mar; 24(3):977-989. PubMed ID: 36974553 [TBL] [Abstract][Full Text] [Related]
11. Preparation and Characterization of Capsaicin Encapsulated Polymeric Micelles and Studies of Synergism with Nicotinic Acids as Potential Anticancer Nanomedicines. Shamsheer R; Sunoqrot S; Kasabri V; Shalabi D; Alkhateeb R; Alhiari Y; Ababneh R; Ikhmais B; Abumansour H J Pharm Bioallied Sci; 2023; 15(3):107-125. PubMed ID: 37705853 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compounds. Mamdooh N; Kasabri V; Al-Hiari Y; Almasri I; Al-Alawi S; Bustanji Y Drug Dev Res; 2019 May; 80(3):310-324. PubMed ID: 30511444 [TBL] [Abstract][Full Text] [Related]